Hawthorn Resources Limited (ASX:HAW) Quarterly Activities Report
Hawthorn Resources Limited (ASX:HAW) highlights significant advancements in the Mt Bevan magnetite project and ongoing developments in the Anglo Saxon gold initiatives.

Hawthorn Resources Limited (ASX:HAW) highlights significant advancements in the Mt Bevan magnetite project and ongoing developments in the Anglo Saxon gold initiatives.
EVE Health Group (ASX:EVE) shares updates on its operational achievements and financial performance, focusing on growth and strategic initiatives.
KNeoMedia Limited (ASX: KNM) outlines key financial developments and contract progress in its quarterly update.
Avecho Biotechnology Limited reports progress in its Phase III CBD clinical trial and significant manufacturing achievements in Q4 2024.
Paradigm Biopharmaceuticals announces key achievements in its December 2024 quarterly activities, including successful FDA protocol clearance and financial highlights.
Dome Gold Mines Limited (ASX:DME) highlights project progress and financial stability in its December quarter activities report.
Bluechiip Limited (ASX:BCT) updates on its strategic review and financial support from shareholders while aiming to lift share suspension.
Zelira Therapeutics secures US$681,000 funding for its HOPEĀ® program and updates operational progress for Q2 FY2025.
Far East Gold Ltd (ASX:FEG) reports significant exploration advancements and robust investment updates for the December quarter.
HITIQ LTD extends its Premier League partnership and secures $3 million in funding to drive growth in concussion management technologies.